This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Glaxo Group Limited, Glaxogrouplimited. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Philip Alan Skone: Innovator in Glucocorticoid Research
Introduction
Philip Alan Skone is a notable inventor based in Stevenage, GB, recognized for his contributions to pharmaceutical innovations. With a portfolio of 3 patents, Skone has focused on developing compounds that address significant medical challenges, particularly in the realm of inflammation, allergies, and autoimmune conditions.
Latest Patents
His latest patents include groundbreaking work on **Non-steroidal glucocorticoid inhibitors and their use in treating inflammation, allergy and auto-immune conditions**. This patent details compounds of formula (I) and outlines methods for their preparation and pharmaceutical compositions that contain these compounds. Skone’s work significantly aims to provide effective therapeutic treatments targeting inflammation, allergy, and autoimmune disorders.
Another significant patent is centered around **Indazoles as glucocorticoid receptor ligands**. This invention also presents a compound of formula (I), showcasing Skone's continuous commitment to advancing medical science through innovative solutions.
Career Highlights
Throughout his career, Philip Alan Skone has worked with prominent companies such as **Glaxo Group Limited**, where he leveraged his expertise to contribute to notable research and product development in the pharmaceutical industry. His work at these organizations highlights his dedication to enhancing therapeutic options in healthcare.
Collaborations
In his career, Skone has had the privilege of collaborating with other professionals, including Simon John Fawcett MacDonald and Anthony William James Cooper. These partnerships showcase a network of talented individuals who share a common vision of advancing medical research and innovation.
Conclusion
Philip Alan Skone stands out as an influential inventor whose work has the potential to transform treatment modalities in areas like inflammation and autoimmune conditions. With a strong foundation in pharmaceutical research and collaboration, Skone continues to contribute to advancements that may positively impact countless lives. His patents reflect not only his creativity and expertise but also his commitment to addressing critical health challenges through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile